DNOW (DNOW) director records share awards and tax-withholding disposals
Rhea-AI Filing Summary
DNOW Inc. director and officer David A. Cherechinsky reported equity-related transactions in common stock tied to restricted and performance share awards. On February 20, 2026, he disposed of 52,558 shares and 35,414 shares at $13.23 per share through tax-withholding dispositions related to vesting awards. He also acquired 89,995 shares for no cash consideration upon satisfaction of performance criteria under a performance share award. After these transactions, his directly held common stock positions reported in the filing increased compared with the prior award vesting, reflecting the net impact of award settlement and related tax withholding.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,023 shares
Net Buy
3 txns
Insider
Cherechinsky David A
Role
See remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common stock | 52,558 | $13.23 | $695K |
| Grant/Award | Common stock | 89,995 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common stock | 35,414 | $13.23 | $469K |
Holdings After Transaction:
Common stock — 960,261 shares (Direct)
Footnotes (3)
- F1. Represents the number of shares withheld from the vesting of restricted shares to satisfy tax withholding liability.
- F2. These shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance shares.
- F3. Represents the number of shares withheld from the vesting of performance award shares to satisfy tax withholding liability.
FAQ
What insider transactions did DNOW (DNOW) report for David A. Cherechinsky?
DNOW reported that David A. Cherechinsky had equity-related transactions involving restricted and performance share awards. He had shares withheld to cover tax liabilities and received additional common shares upon meeting performance criteria, all reflected as direct ownership changes on February 20, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.